RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

161 hedge funds and large institutions have $3.39B invested in Ultragenyx Pharmaceutical in 2015 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 89 increasing their positions, 30 reducing their positions, and 22 closing their positions.

Holders
161
Holders Change
+10
Holders Change %
+6.62%
% of All Funds
4.5%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
33
Increased
89
Reduced
30
Closed
22
Calls
$21.7M
Puts
$35.6M
Net Calls
-$13.9M
Net Calls Change
-$8.62M

Top Buyers

1
Wells Fargo
1
Wells Fargo
California
$150M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$559M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$204M
4
EAM
4
Eagle Asset Management
Florida
$34.1M
5
Goldman Sachs
5
Goldman Sachs
New York
$51.8M

Top Sellers

1
CWAM
1
Columbia Wanger Asset Management
Illinois
$121M
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$22.3M
3
Fidelity International
3
Fidelity International
Bermuda
$0
4
Franklin Resources
4
Franklin Resources
California
$0
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$42.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
MACM
176
March Altus Capital Management
Connecticut
– -$338K -3,299 Closed
M&T Bank
177
M&T Bank
New York
– -$276K -2,694 Closed
HSBC Holdings
178
HSBC Holdings
United Kingdom
– -$219K -2,141 Closed
FANJ
179
Financial Architects (New Jersey)
New Jersey
– -$141K -1,380 Closed
DADC
180
D.A. Davidson & Co
Montana
– -$7K -70 Closed
Invesco
181
Invesco
Georgia
– -$5K -53 Closed
TRCT
182
Tower Research Capital (TRC)
New York
– -$5K -50 Closed
4 5 6 7
8